lecture 26 Flashcards

1
Q

what is type 1 diabetes?

A

-polygenic disorder
-autoimmune destruction of insulin producing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is type 2 diabetes?

A

-polygenic disorder
-defects in insulin action (obesity)
-defects in glucose-induced insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the complications with diabetes?

A

retinopathy (sight)
nephropathy (kidney function)
peripheral neuropathy (feet)
autonomic neuropathy (cardiovascular, gut)
macrovascular (heart attack, stroke)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which type of diabetes associates with obesity?

A

type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why does obesity increase diabetes risk?

A

-associated with insulin resistance and enlargement of islets
-balance between lifestyle and B cell compensation (genetics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when does type 2 diabetes develop?

A

once beta cells can no longer compensate for insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is type 2 diabetes developed from unhealthy lifestyle?

A

-increased obesity
-increased insulin resistance
-susceptible beta cells
-beta cell dysfunction and failure
-hyperglycaemia
-type 2 diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the therapy for type 2 diabetes?

A

-lifestyle changes (diet and increased exercise)
-drugs - mono therapy (metformin) or combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how is carbohydrate absorption targeted?

A

-inhibiting carb digestion with alpha-glucoside inhibitors (AGIs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are AGIs?

A

competitive inhibitors
convert oligosaccharides to glucose
1st gen -> acarbose -> not abosrbed
2nd gen -> miglitol ->absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the benefits of AGI?

A

-decreases intestinal glucose absorption
-decreases glycemic index of food
-decreases post prandial blood (glucose) and triglycerides
-no risk of hypoglycaemia (too low glucose levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the adverse effects of AGI?

A

-abdominal discomfort as undigested carbs move from small intestine to colon
-fermentation of undigested carbs in colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is renal glucose excretion increased?

A

-by inhibiting SGLT2 in kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what do SGLTs do?

A

They are symporters of glucose and sodium > use sodium gradient (‘active transporter’ > Na+ must be pumped out)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the function of SGLT2 inhibitors?

A

prevent reabsorption of glucose causing excretion in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where is SGLT2 expressed?

A

kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where is SGLT1 expressed?

A

kidney and intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the inhibitors of SGLT2?

A

-phlorizin (non selective naturally occuring)
-sergiflozin and dapagliflozin (selective inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what does phlorizin do?

A

inhibits intestinal and renal absorption of glucose
lowers blood glucose
inhibits SGLT1 and 2

20
Q

what does sergiflozin and dapagliflozin do?

A

-cause inhibition of renal glucose re-absorption
-lower blood glucose
-weight loss
-inhibits SGLT2

21
Q

what are the adverse effects/risks of using SGLTs?

A

increased urine volume
risk of urinary tract infections (UTIs)
risk of genital fungal infections

22
Q

how is insulin secretion targeted?

A

sulphonylureas
GLP-1R agonists
DPP4 inhibitors

23
Q

how do sulphonylureas work?

A

-bind to SUR1
-close the K-ATP channel
-membrane depolarisation
-increase insulin secretion

24
Q

what are incretins?

A

intestinal peptides produced in response to food that stimulate insulin secretion
GIP and GLP1

25
what is GIP?
-glucose dependent insulinotropic peptide -secreted from K cells in small intestine -inhibits gastric motility, stimulates insulin secretion -has inhibitory effect on appetite
26
what is GLP1?
-glucagon like peptide 1 -secreted from L cells of colon -stimulates insulin secretion by beta cells -suppresses appetite in brain -used in treatment of obesity
27
what is an example of a GIP agonist?
tirzepatide
28
what is an example of a GLP-1 agonist?
-exenatide -liraglutide -semaglutide
29
what is the mechanism of action of GLP-1 on islet beta cells?
1. bind to GLP-1 receptor 2. increases cAMP 3. increases PKA 4. increases cAMP guanine nucleotide exchange factor 5. increased ca2+ 6. decreased K ATP channel 7. increased insulin secretion
30
what causes degradation of incretins?
DPP-4 (dipeptidyl peptidase 4) cleaves the first 2 residues to become inactive
31
what 2 forms does DPP4 exist as?
1. membrane anchored extracellular enzyme 2. soluble form (retains catalytic activity)
32
what are the benefits of sulphonylureas?
-decreases blood glucose -increases insulin secretion
33
what are the risks of sulphonylureas?
-increased risk of hypoglycaemia -increased weight gain -increased cardiovascular events
34
what are the benefits of GLP-1R agonists and DPP4 inhibitors?
-decrease blood gluciose -increased insulin secretion -decrease glucagon secretion -no risk of hypoglycaemia -decreased food intake and body weight
35
what are the potential risks of GLP-1R agonists and DPP4 inhibitors?
pancreatitis or pancreatic cancer gastric discomfort
36
what are the two ways adipose tissue expands in obesity?
1. fat cell hypertrophy (increases in cell volume) 2. fat cell hyperplasia (increase in cell number/adipogenesis)
37
what happens when adipocytes attain their max capacity of lipid storage?
lipid leaves are raised in blood and other tissues
38
what are PPAR-gamma drugs?
favour adipocyte proliferation and further lipid storage prevents damage by lipids in other organs
39
what do TZDs do?
-decrease blood glucose -decrease blood insulin -decrease blood triglycerides -increase insulin sensitivity
40
what does PPAR gamma do?
transcription factors that promotes adipocyte proliferation and differentiation
41
how is PPAR gamma activated?
1. ligand binding to PPAR gamma 2. heterodimer with retinoid acid receptor 3. recruitment to PPRE on DNA promoter 4. recruitment of co-activator (eg. P300-histone acetylase) 5. acetylation of histones exposes chromatin 6. increased transcription of PPAR gamma target genes
42
what are the benefits of TZDs?
-lower blood glucose and insulin -increased insulin sensitivity in obesity
43
what are the risks of TZDs?
increases body weight can cause liver damage heart attack risk
44
which TZD is currently in clinical use?
pioglitazone
45
what are the biological effects of metformin?
-decreased hepatic glucose production -increased fatty acid oxidation -increased insulin sensitivity -increased glucose utilisation
46
what is the mechanism of metformin?
1. enter cells via OCT1 2. accumulates in energised mitochondria (-ve charge inside) 3. inhibits complex I 4. decreases ATP/ADP (decreases energy for gluconeogenesis) 5. increases AMP (inactivates adenyl cyclase, prevents glucagon signalling, decreases gluconeogenesis) 6. AMPK activation (increased fatty acid oxidation, decreased fatty acid synthesis)
47